KHADGA RAJ ARAN

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (102)

• The brain renin–angiotensin system in Parkinson’s disease: Friend or foe? mechanistic insights and therapeutic implications
  Ageing Research Reviews 2026 DOI: 10.1016/j.arr.2026.103230
  +Save
• Epitranscriptomic imprints on glial cell polarization: METTL3/IGF2BP2 axis as a driver of neurodegeneration in Alzheimer’s disease
  Psychopharmacology 2026 DOI: 10.1007/s00213-026-07137-1
  +Save
• Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure
  Cardiovascular Drugs and Therapy 2026 DOI: 10.1007/s10557-025-07830-x
  +Save
• Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson’s disease
  Metabolic Brain Disease 2026 DOI: 10.1007/s11011-026-01907-8
  +Save
• The emerging role of FGF21 in alcohol consumption and dependence: mechanisms and therapeutic prospects
  Gene 2026 DOI: 10.1016/j.gene.2026.150150
  +Save
• microRNA-124 in Alzheimer’s Disease: Bridging Neuro-regulation and Emerging Therapeutic Strategies
  Current Pharmacology Reports 2026 DOI: 10.1007/s40495-026-00454-1
  +Save
• Decoding the RNA Shield: HNRNPC and YTHDF2 Act as Guardians of Neurons in Parkinson’s Disease
  Neurotoxicity Research 2026 DOI: 10.1007/s12640-026-00790-6
  +Save
• PAR-1 in Alzheimer’s Disease: Pathophysiological Insights and Mechanistic Perspectives
  Current Medical Science 2026 DOI: 10.1007/s11596-026-00175-y
  +Save
• Role of LncRNA NEAT1 in Alzheimer’s Disease: Pathophysiological Insights and Therapeutic Approaches
  Neurotoxicity Research 2026 DOI: 10.1007/s12640-026-00792-4
  +Save
• Symbiotic in Alzheimer’s disease: modulating the gut-brain axis for neuroimmune homeostasis and cognitive protection
  Inflammopharmacology 2026 DOI: 10.1007/s10787-026-02180-y
  +Save